Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 2Pancreatic cancer, adult 1Osteosarcoma 1Neoplasms 1NSCLC 1Locally Advanced Pancreatic Cancer 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Advanced Pancreatic Cancer 1Adenoma, Islet Cell 1

Interventions

surufatinib 1nimotuzumab 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Adenoma, Islet Cell × surufatinib × Clear all
NCT06158516 2023-12-06

A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors

Changhai Hospital

Phase 2 Not yet recruiting
100 enrolled

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡